Markets
Neutral
Arvinas to Present Data from the Vepdegestrant Clinical Development Program at the 2025 European Society for Medical Oncology (ESMO) Congress
Breaking news from global financial markets
il y a 3 semaines
Lire Plus
il y a 3 semaines
1,914
il y a 3 semaines
3,561
il y a 3 semaines
1,253
il y a 3 semaines
1,268
il y a 3 semaines
3,691
JASPORT stärkt den Trend zu Heimfitness mit Heimtrainer Fahrrad, Rudergerät und Laufband für Zuhause
Markets
il y a 3 semaines
3,993
il y a 3 semaines
2,620
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
Markets
il y a 4 semaines
691
il y a 4 semaines
4,130
HomeInherit Introduces Investment Model Offering Seniors Liquidity Without Leaving Their Homes
Markets
il y a 4 semaines
2,212
il y a 4 semaines
2,114
il y a 4 semaines
3,804
il y a 4 semaines
4,931
il y a 4 semaines
821
Tendances Actuelles
1
IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...
25,435
il y a 2 jours
2
BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...
5,692
il y a 2 jours
3
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...
32,440
il y a 2 jours
4
BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading
9,183
il y a 2 jours
5
Trex Company, Inc. (TREX) Faces Investor Scrutiny Amid Disappointing Q3, Revised...
28,422
il y a 2 jours